Shares of Immunovative Inc. (PINK: IMUN), owner of an exclusive, worldwide license to commercialize any products covered under Immunovative Therapies Ltd.’s current issued and pending patent application portfolio, are soaring in trading today.
At last check, IMUN shares were trading 45.14% higher at $0.254 on above average volume of 4.08 million. The stock touched an all-time high of $0.27 in trading today.
Immunovative shares are soaring today after the company announced the launch of a new website www.IMUN.com. The website includes information on technology, product candidates, management team, videos and links to the company’s social media sites.
IMUN also announced the launch of ImmuNews, which is a monthly newsletter designed to provide information to the company’s shareholders of happenings in the rapidly developing field of cancer immunotherapy and to provide updates on the company’s progress toward bringing its own products to market.